Prediction of neutropenia

International Journal of Antimicrobial Agents

Volumn 16, Issue 2, 2000, Pages 113-115

  Rolston, Kenneth V I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Febrile; Neutropenia; Risk based

Indexed keywords

ANTIBIOTIC AGENT;

FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HUMAN; INFECTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

EID: 0033780528     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00215-6     Document Type: Article

References (11)

1. Overview of the problem of infection in the immunocompromised host
2. Quantitative relationship between circulating leukocytes and infections in patients with acute leukemia
3. Controversies in the management of febrile neutropenic cancer patients
4. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
5. Risk assessment in cancer patients with fever and neutropenia. A prospective, two-center validation of a prediction rule
6. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy
7. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer: oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
8. Home antibiotic therapy for low risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule
9. Feasibility of out-patient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial
10. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer